CLINICAL_TRIALS ClinicalTrials.gov record update

177Lu-PSMA-617 (Pluvicto) for the Treatment of Patients With Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Super Scan Bone Scan

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06972628
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:48.316003+00:00
Published At: 2025-05-15T00:00:00+00:00
Record Updated At: 2025-05-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Castration-Resistant Prostate Cancer", "Prostate Cancer Patients With Bone Metastasis", "Prostate Cancer (CRPC)", "Prostate Cancer", "Prostate Cancer Metastatic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-15"
protocolSection.identificationModule.nctId: "NCT06972628"
protocolSection.identificationModule.officialTitle: "177Lu-PSMA-617 (Pluvicto) for the Treatment of Patients With Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Super Scan Bone Scan"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.